Related Experiment Video

Updated: Sep 23, 2025

Using the BLT Humanized Mouse as a Stem Cell based Gene Therapy Tumor Model
06:59

Using the BLT Humanized Mouse as a Stem Cell based Gene Therapy Tumor Model

Published on: December 18, 2012

18.9K

Gene Therapy and the Use of Animal Models: Why Mice Alone Are Not Sufficient

Alisha M Gruntman1,2,3, Terence R Flotte1,2

  • 1Horae Gene Therapy Center and.

Human Gene Therapy
|May 16, 2022
PubMed
Abstract

No abstract available in PubMed .

More Related Videos

Generation of Genetically Modified Mice through the Microinjection of Oocytes
10:19

Generation of Genetically Modified Mice through the Microinjection of Oocytes

Published on: June 15, 2017

20.9K
Author Spotlight: Modeling Brain Tumors In Vivo Using Electroporation-Based Delivery of Plasmid DNA Representing Patient Mutation Signatures
04:01

Author Spotlight: Modeling Brain Tumors In Vivo Using Electroporation-Based Delivery of Plasmid DNA Representing Patient Mutation Signatures

Published on: June 23, 2023

1.9K

Related Experiment Videos

Last Updated: Sep 23, 2025

Using the BLT Humanized Mouse as a Stem Cell based Gene Therapy Tumor Model
06:59

Using the BLT Humanized Mouse as a Stem Cell based Gene Therapy Tumor Model

Published on: December 18, 2012

18.9K
Generation of Genetically Modified Mice through the Microinjection of Oocytes
10:19

Generation of Genetically Modified Mice through the Microinjection of Oocytes

Published on: June 15, 2017

20.9K
Author Spotlight: Modeling Brain Tumors In Vivo Using Electroporation-Based Delivery of Plasmid DNA Representing Patient Mutation Signatures
04:01

Author Spotlight: Modeling Brain Tumors In Vivo Using Electroporation-Based Delivery of Plasmid DNA Representing Patient Mutation Signatures

Published on: June 23, 2023

1.9K

Related Concept Videos

Mouse Models of Cancer Study02:43

Mouse Models of Cancer Study

5.7K
Mice have long served as models for studying human biology and pathology because of their phylogenetic and physiological similarity with humans. They are also easy to maintain and breed in the laboratory, and hence, many inbred strains are now available for research. Studies on mice have contributed immeasurably to our understanding of cancer biology.
The development of transgenic, knockout, and knock-in mice has led to an exponential increase in their use as model organisms in research,...
5.7K
In-vitro Mutagenesis01:16

In-vitro Mutagenesis

14.3K
To learn more about the function of a gene, researchers can observe what happens when the gene is inactivated or “knocked out,” by creating genetically engineered knockout animals. Knockout mice have been particularly useful as models for human diseases such as cancer, Parkinson’s disease, and diabetes.
14.3K

Articles linked to this work by shared authors, journal, and citation graph.

Optimization of Alpha-1 Antitrypsin Expression from Adeno-Associated Virus Vectors.

Human gene therapy·2026

Immune Toxicities in AAV Gene Therapy: Overview for Clinicians.

International journal of molecular sciences·2026

AAV9 Gene Therapy in Type II GM1 Gangliosidosis - A Phase 1-2 Trial.

The New England journal of medicine·2026

Advances in Precision Editing Therapies for Alpha-1 Antitrypsin Deficiency.

Human gene therapy·2026

Overcoming barriers to commercially pre-viable gene and cell therapies for rare and ultra-rare diseases.

Molecular therapy : the journal of the American Society of Gene Therapy·2025

A single amino acid variant in the variable region I of AAV capsid confers liver detargeting.

PLoS pathogens·2025

Regulatory Progress in the Clinical Translation of Gene Therapy in China: Evolution, Challenges, and Future Perspectives.

Human gene therapy·2026

Practical Considerations for Gene and Cell Therapy Delivery in Temporal Lobe Epilepsy and Other Neurological Disorders.

Human gene therapy·2026

Development of a Recombinant Adeno-Associated Virus Vector for Human T Lymphocyte- and Natural Killer Cell-Targeted Gene Therapy.

Human gene therapy·2026

Development of an AAV-Encoded Adenine Base Editor for Duchenne Muscular Dystrophy.

Human gene therapy·2026

InsightRP2-An Interdisciplinary Approach Toward Therapy Development in RP2-Associated Retinopathy.

Human gene therapy·2026

Chimeric Antigen Receptor T Cell Targeting of Natural Killer Cells in Peripheral Blood and Tissues of Rhesus Macaques.

Human gene therapy·2026

Long-Term Efficacy and Allograft Loss after Immune Checkpoint Inhibitor Therapy in Solid Organ Transplant Recipients with Advanced Cutaneous Squamous Cell Carcinoma.

medRxiv : the preprint server for health sciences·2026

Engineered subtilisin protease degrades active KRAS in cancer cells leading to differential cell targeting.

Research square·2026

Microenvironment-derived acetylated amino acids promote glioblastoma treatment resistance.

Research square·2026

The therapy-conditioned host: a state-transition framework for second primary cancer evolution.

Frontiers in oncology·2026

Cyclopeptide 161 protects human dermal fibroblasts against UV-induced damage via the MEK1/2-ERK1/2 signaling pathway.

Frontiers in physiology·2026

Dynamic clonal evolution of multiple bypass resistance mechanisms in EGFR-mutant lung adenocarcinoma: a case report.

Frontiers in oncology·2026
See all related articles
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies
Jove
Visualize
Contact Us